Co-Founder

Dr. Thomas Stegmann is a Cardiothoracic Surgeon and Professor of Surgery and – from December 01, 1984, until March 31, 2006 - Director of the Department of Thoracic and Cardiovascular Surgery at the Fulda Medical Center in Fulda, Germany. Dr. Stegmann received his medical degree (summa cum laude) from Heidelberg University, Heidelberg, Germany and completed a doctoral thesis as part of that degree. The thesis, entitled “Content of Catecholamines and Change in Enzyme-activities of the Cardiac Muscle in experimentally hypertrophied Hearts” was awarded the prize for “Best Dissertation” by the Medical Faculty of the University of Heidelberg.

Dr. Stegmann continued his medical training in General and Cardiovascular Surgery in the Department of Surgery at the Hannover Medical School, Hannover, Germany, where he was awarded the “Rudolf-Nissen-Memorial-Prize” by the German Society for Thoracic and Cardiovascular Surgery. Following his residency training in the Division of Thoracic and Cardiovascular Surgery at the Hannover Medical School, Germany, he was appointed Professor of Surgery at Hannover Medical School.

From 1985 until March 2006, he has held the position of Director of the Department of Thoracic and Cardiovascular Surgery at Fulda Medical Center, Germany, and has also been a Member of the Faculty of Hannover Medical School. His main areas of research interests include coronary surgery, surgery for aortic diseases (especially aortic dissection), heart valve surgery, heart and lung transplantation, vascular surgery, pacemaker- and AICD-surgery, surgery of the esophagus, neo-angiogenesis in the heart and the role of human growth factors.

Dr. Stegmann has been a Faculty Member of the Transcatheter Cardiovascular Therapeutics (TCT) annual conference, a worldwide physicians meeting held in Washington, D.C., each fall. Dr. Stegmann is known internationally for his pioneer work in inducing angiogenesis (the growth of new vessels) in the heart. Dr. Stegmann has published and lectured widely in this area. His landmark clinical trials with FGF in inducing angiogenesis in the heart have been published in prestigious medical journals including “Circulation” and “Journal of Cardiac and Vascular Regeneration” and have been reported on in the “New York Times” and the “Wall Street Journal”.

In 2004, he published the book: “New Vessels for the Heart”, in 2007 he published the book: “Holding a Woman’s Heart in My Hands”. Dr. Stegmann is a member of the New York Academy of Sciences and a member of the Ukrainian Academy of Medical Sciences.

Dr. Stegmann now serves on the board of directors for CardioVascular BioTherapeutics, Inc. (CVBT), a Las Vegas based Biotech Company.

< Back to Scientists

< Back to Officers & Key Personnel

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.